Old Web
English
Sign In
Acemap
>
authorDetail
>
Rowan L. Callahan
Rowan L. Callahan
Oregon Health & Science University
Myeloid leukemia
Cancer research
Leukemia
Mutant
JAK-STAT signaling pathway
3
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia
2021
bioRxiv
Sarah A. Carratt
Theodore P. Braun
Cody Coblentz
Zachary Schonrock
Rowan L. Callahan
Brittany M. Smith
Lauren Maloney
Amy Foley
Julia E. Maxson
Show All
Source
Cite
Save
Citations (0)
FLT3 and LSD1 Inhibitor Combinations Synergistically Repress Growth of FLT3-Mutant Acute Myeloid Leukemia Via Blockage of MYC Function
2020
Blood
Daniel J. Coleman
Brittany M. Smith
Cody Coblentz
Rowan L. Callahan
Jake VanCampen
Garth L. Kong
Brian J. Druker
Julia E. Maxson
Theodore P. Braun
Show All
Source
Cite
Save
Citations (0)
Combined inhibition of JAK/STAT pathway and lysine-specific demethylase 1 as a therapeutic strategy in CSF3R/CEBPA mutant acute myeloid leukemia.
2020
Proceedings of the National Academy of Sciences of the United States of America
Theodore P. Braun
Cody Coblentz
Brittany M. Smith
Daniel J. Coleman
Zachary Schonrock
Sarah A. Carratt
Rowan L. Callahan
Breanna Maniaci
Brian J. Druker
Julia E. Maxson
Show All
Source
Cite
Save
Citations (12)
1